Healthcare - Biotechnology - NASDAQ - US
$ 0.814
-2.78 %
$ 102 M
Market Cap
-0.78
P/E
INCOME STATEMENT
146 M
REVENUE
-130 M
OPERATING INCOME
-143 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Karyopharm Therapeutics Inc.
| Revenue | 146 M |
| Cost Of Revenue | 4.94 M |
| Gross Profit | 141 M |
| Operating Expenses | 271 M |
| Operating Income | -130 M |
| Other Expenses | 13.6 M |
| Net Income | -143 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||
| Revenue | 146.0 | 157.1 | 209.8 | 108.1 | 40.9 | 30.3 | 1.6 | 0.2 | 0.2 | 0.2 | 0.4 | 0.6 | 0.2 |
| GROSS PROFIT | |||||||||||||
| Cost Of Revenue | 4.9 | 5.2 | 3.4 | 2.7 | 2.4 | 161.4 | 107.3 | 86.9 | 97.7 | 60.1 | 28.5 | 14.1 | 0 |
| Gross Profit | 141.1 | 151.9 | 206.4 | 105.4 | 38.5 | (131.0) | (105.7) | (86.8) | (97.5) | (59.9) | (28.1) | (13.5) | 0.2 |
| OPERATING INCOME | |||||||||||||
| Operating Expenses | 270.6 | 294.1 | 304.7 | 277.2 | 227.8 | 210.2 | 132.1 | 110.9 | 119.3 | 76.1 | 34.3 | 16.5 | 10.5 |
| Selling, General and Administrative Expenses | 131.9 | 145.4 | 143.8 | 126.4 | 105.4 | 48.8 | 24.9 | 23.9 | 21.6 | 15.9 | 5.9 | 2.4 | 1.8 |
| Research and Development Expenses | 138.8 | 148.7 | 160.8 | 150.8 | 122.3 | 161.4 | 107.3 | 86.9 | 97.7 | 60.1 | 28.5 | 14.1 | 8.6 |
| Operating Income | (129.5) | (142.2) | (98.3) | (171.8) | (189.3) | (179.9) | (130.5) | (110.7) | (119.1) | (75.8) | (34.0) | (15.9) | (10.3) |
| PRE-TAX INCOME | |||||||||||||
| Interest Income Expense | 23.8 | 25.0 | 26.0 | 27.1 | 15.6 | 2.5 | 0 | 0 | 0 | 1 K | 0 | 0 | 0 |
| Total Other Income | (13.2) | (22.7) | (25.5) | (24.1) | (10.3) | 1.5 | 1.6 | 1.3 | 0.9 | 69 K | 3 K | 2 K | 0 |
| Pre-Tax Income | (142.8) | (164.9) | (123.8) | (196.0) | (199.6) | (178.4) | (128.9) | (109.4) | (118.2) | (75.8) | (33.9) | (15.9) | (10.3) |
| NET INCOME | |||||||||||||
| Tax Provision | 0.3 | 0.4 | 0.3 | 0.3 | 40 K | 26 K | 63 K | 0.1 | (0.9) | 69 K | 3 K | 2 K | 0 |
| Net Income | (143.1) | (165.3) | (124.1) | (196.3) | (199.6) | (178.4) | (129.0) | (109.6) | (118.2) | (75.8) | (33.9) | (15.9) | (10.3) |
| EPS | 1.25 | 2.02 | 1.65 | 2.72 | 3.22 | 3.14 | 2.81 | 2.92 | 3.32 | 2.43 | 5.59 | 6.64 | 10.3 |